Sherbrooke Park Advisers’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,399
Closed -$39.6K 1339
2024
Q2
$39.6K Sell
15,399
-58,125
-79% -$149K 0.01% 862
2024
Q1
$362K Buy
+73,524
New +$362K 0.07% 489